The need for axillary dissection (AD) is declining, but it is still essential for many patients with nodal involvement who risk developing breast‐cancer–related lymphedema (BCRL) with lifelong consequences. Previous nonrandomized… Click to show full abstract
The need for axillary dissection (AD) is declining, but it is still essential for many patients with nodal involvement who risk developing breast‐cancer–related lymphedema (BCRL) with lifelong consequences. Previous nonrandomized studies found axillary reverse mapping and selective axillary dissection (ARM‐SAD) a safe and feasible way to preserve the arm's lymphatic drainage.
               
Click one of the above tabs to view related content.